staurosporine aglycone has been researched along with Nasopharyngeal Neoplasms in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ng, YK | 1 |
| Wong, EY | 1 |
| Lau, CP | 1 |
| Chan, JP | 1 |
| Wong, SC | 1 |
| Chan, AS | 1 |
| Kwan, MP | 1 |
| Tsao, SW | 1 |
| Tsang, CM | 1 |
| Lai, PB | 1 |
| Chan, AT | 1 |
| Lui, VW | 1 |
1 other study available for staurosporine aglycone and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.
Topics: Anoikis; Antineoplastic Agents; Brain-Derived Neurotrophic Factor; Carbazoles; Carcinoma; Cell Adhes | 2012 |